Royal Bank of Canada
ABVC icon

Royal Bank of Canada’s ABVC BioPharma ABVC Stock Holding History

Royal Bank of Canada’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
17
– – ﹤0.01% 7339
2026
Q1 		$0 Buy
+17
New +$28 ﹤0.01% 7039
2024
Q3 		– Sell
-37
Closed – – 6782
2024
Q2 		$0 Hold
37
– – ﹤0.01% 6972
2024
Q1 		$0 Hold
37
– – ﹤0.01% 6941
2023
Q4 		$0 Hold
37
– – ﹤0.01% 7050
2023
Q3 		$0 Sell
37
-1
-3% -$2 ﹤0.01% 7020
2023
Q2 		$0 Buy
+38
New +$253 ﹤0.01% 7192
2022
Q4 		– Sell
-24
Closed – – 7162
2022
Q3 		$0 Buy
+24
New +$202 ﹤0.01% 7389

Other funds holding ABVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada's ABVC Position: Q2 2026 in Review

Royal Bank of Canada held its ABVC BioPharma (ABVC) position steady in Q2 2026 at 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7339.

Royal Bank of Canada first reported a position in ABVC in Q3 2022 and has held it in 8 quarters since. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

  • Royal Bank of Canada held 17 shares of ABVC BioPharma worth $0 as of Q2 2026.
  • Royal Bank of Canada left its ABVC BioPharma share count unchanged in Q2 2026.
  • ABVC BioPharma made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7339 holding.
  • Royal Bank of Canada first reported a position in ABVC BioPharma in Q3 2022 and has held it in 8 quarters since.
  • 15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.